CHANGZHOU, China, Aug. 17,
2023 /PRNewswire/ -- Jin Medical International
Limited ("the Company" or "JinMed") (NASDAQ: ZJYL), the world's
leading provider of rehabilitation equipment, rang the bell at the
New York Stock Exchange by its Chairman and CEO Wang Erqi on August
17, to celebrate the Company's official listing. JinMed has
been publicly traded on the Nasdaq Capital Market since
March 28, 2023.
Since its establishment in 2006, JinMed has been committed to
providing more comfortable, convenient, and safe products for
socially disadvantaged groups. JinMed focuses on R&D and
manufacturing high-end rehabilitation equipment. Its products
include walking aids, breathing medical equipment, intelligent nano
bath equipment, and Leyu series products for the elderly and
patients, fitness equipment for the elderly and special groups, and
disaster relief products. Currently, the company's nano bathing
products have been granted an invention patent and four utility
model patents, garnering significant market recognition.
Driven by the principles of "care in every product" and the
integration of "comfort and design, backed by medical research",
JinMed will continue to prioritize technological innovation as the
driving force for its business development. On the basis of having
provincial engineering technology research centers, provincial
industrial technology centers, and other R&D institutions, it
has deep cooperation with world-class R&D institutions and
enterprises in the field of rehabilitation, to expand its market
share through continuous product development. JinMed is achieving
high growth performance as well as fulfilling its social
responsibilities.
About Jin Medical International Ltd.
Founded in 2006
and headquartered at Changzhou
City, Jiangsu Province of
China, the Company, through its
Chinese operating entities, designs and manufactures wheelchairs
and living aids products for people with disabilities, the elderly,
and people recovering from injuries. The Company's Chinese
operating entities operate 2 manufacturing plants with
approximately 228,257 square feet in the aggregate in Changzhou City and Taizhou City, Jiangsu Province, China. The Company's Chinese operating
entities have established relationships with over 40 distributors
in China, and over 20 in the other
regions of the world where it currently sells the products. The
majority of the Company's wheelchair products, with more than 30
models, are sold to dealers in Japan and China, including Nissin Medical Industries
Co., Ltd, one of the largest medical device distributors in
Japan. The Company's Chinese
operating entities own a number of patents with the Patent
Administration Department of the People's
Republic of China and aims to deliver innovative wheelchair
designs that are both lightweight and ergonomic.
For more information, please visit:
http://www.zhjmedical.com.
View original
content:https://www.prnewswire.com/news-releases/jinmed-nasdaq-zjyl-rings-the-nasdaq-stock-market-closing-bell-on-august-17-301904286.html
SOURCE Jin Medical International Ltd
